产品中心
APls
您的位置：首页 > 产品中心 > 搜索结果
|
Name
|
CAS No.
|
Usage
|
Status
|
|
Eltrombopag
Olamine
|
496775-62-3
|
Low Blood
|
US DMF 38914
|
|
Platelet Count
|
NMPA Approval Y20230000603
|
|
Trametinib(DMSO)
|
1187431-43-1
|
Melanoma
|
Validation & Registration in 2025
|
|
Dabrafenib Mesylate
|
1195768-06-9
|
Melanoma
|
Validated
|
WC Available
|
|
Ibrutinib(Form A)
|
936563-96-1
|
Leukemia (CLL/MCL)
|
NMPA CDE
|
|
Y20230001268
|
|
Tepotinib
|
1100598-32-0
|
NSCLC
|
Validated & registration in 2025
|
|
Hydrochloride
|
1946826-82-9
|
|
Etrasimod
|
1206123-37-6
|
Ulcerative Colitis (UC)
|
Under Validation
|
|
Arginine
|
1206123-97-8
|
|
Fezolinetant
|
1629229-37-3
|
VMS Caused by
Menopause
|
Under
Validation
|
|
Sparsentan
|
254740-64-2
|
IgA Nephropathy
|
Pilot
|
|
Maralixibat HCl
|
228113-66-4
|
Cholestatic
Itching
|
Under R&D
|
|
Capivasertib
|
1143532-39-1
|
Breast Cancer
|
Pilot
|
